Image pharmaphorum Editor News May champions AI-backed R&D into cancer and chronic disease Theresa May has pledged to prioritise artificial intelligence (AI) so chronic diseases are diagnosed at an early stage, potentially saving many lives. News SMEs: the next generation of pharma News Patient-centricity in RWE: fine words, fiction or facts? The perennial challenge for pharmaceutical companies that espouse a patient-centric approach to their activities is being able to prove that they can ‘walk the talk’ when it comes to being closer t News Roche haemophilia data piles pressure on Shire Hemlibra threatens to take market share from Advate Load more results
News May champions AI-backed R&D into cancer and chronic disease Theresa May has pledged to prioritise artificial intelligence (AI) so chronic diseases are diagnosed at an early stage, potentially saving many lives.
News Patient-centricity in RWE: fine words, fiction or facts? The perennial challenge for pharmaceutical companies that espouse a patient-centric approach to their activities is being able to prove that they can ‘walk the talk’ when it comes to being closer t
News Roche haemophilia data piles pressure on Shire Hemlibra threatens to take market share from Advate
News Astellas bets on Vir cancer drug, and other licensing deals Our latest round-up of pharma licensing deals features assets from Vir Biotech, Harbour BioMed, Unnatural Products, Genhouse, and CSL.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
